FOXD3-induced miR-133a blocks progression and metastasis of colorectal cancer through regulating UBA2

Abstract

Background and Aim: Some studies have verified that miR-133a played an inhibitory role in several cancers. Whereas, the effect of miRNA-133a in colorectal cancer (CRC) has not been fully elucidated. Our study aims to confirm UBA2 as a direct target gene of miRNA-133a and explore the upstream modulatory molecules of miR-133a. In addition, their impacts on the biological characteristics of CRC cells were assessed. Methods: QRT-PCR analyzed miR-133a expression levels in colorectal cells including HCT116, SW48 cells and human normal colorectal cell line NCM460. A serial biological experiment assessed miR-133a effects on cell proliferation, migration, invasion and apoptosis capacities in HCT116 and SW48 cells. MiRNA targeting gene prediction and a dual luciferase assay were employed to confirm miR-133a-targeted UBA2. Transcription factors (TFs) FOXD3 was identified as an upstream regulator of miR-133a via JASPAR. The influence of miR-133a and FOXD3 on UBA2 expression was analyzed by qRT-PCR or western blot. Results: miR-133a was lowly expressed in CRC cells. High miRNA-133a expression suppressed the proliferation, migration, invasion and enhanced apoptosis capacities of CRC cells. MiR-133a targeted the UBA2 mRNA 3ʹUTR area and reduced UBA2 protein expression. We also unveiled that FOXD3 high-expression significantly raised miR-133a expression and diminished UBA2 expression. We also discovered that high miR-133a expression augmented the effects of elevated FOXD3 expression on CRC cell proliferation, migration and invasion, whereas, low miR-133a expression generated the opposite outcomes. Conclusion: FOXD3 induced miRNA-133a directly targeting UBA2 could affect the progression and growth of CRC.

Identification of differential microRNAs and messenger RNAs resulting from ASXL transcriptional regulator 3 knockdown during during heart development

“…Recent studies have stated that the PI3K-Akt pathway is not only involved in cardiac ischemia-reperfusion injury, cardiac hypertrophy, and cardiac cell remodeling but also influences heart development by regulating the proliferation of cardiac precursor cells [ 60–63 ]. ASXL3, as a transcription factor, can regulate miRNAs [ 64 , 65 ]. The expression of miRNA is substantially reduced after interfering with ASXL3.…”

microRNA-mRNA regulatory network analysis reveals a possible metastatic mechanism of uveal melanoma

“…A study has found that down regulation of FOXD3 could promote the growth, migration, invasion and angiogenesis of neuroblastoma cells [42]. Foxd3 can inhibit the progression and metastasis of colorectal cancer by regulating UBA2 induced by Mir-133a [43]. Meanwhile, a transcriptional analysis of several genes related to tumor metastasis, in-vasion and epithelial-mesenchymal transition (EMT) showed that SPDEF expression could selectively downregulate MMP9 and MMP13 in prostate cancer cells, playing an inhibitory role in tumor metastasis [44].…”

Anticancer Mechanism of Astragalus Polysaccharide and Its Application in Cancer Immunotherapy

“…APS reduced the expression of miR-27a, leading to upregulation of the tumor suppressor gene FBXW7, which ultimately inhibited proliferation and induced apoptosis in OV-90 and SKOV-3 cells [79]. MiR-133a is an oncogene in various cancer types [101][102][103]. APS reduced the expression of MiR-237a by upregulating miR-133a, inactivating the JNK pathway, and exerting anticancer effects in human osteosarcoma MG63 cells [80].…”